FDA Approves Eli Lilly’s Tirzepatide (Zepbound)
The Food and Drug Administration (FDA) has approved Eli Lilly’s tirzepatide, already known as the diabetes drug Mounjaro, for chronic weight management. This move, under the brand name Zepbound, opens the door for wider use of this potentially game-changing medication. How zepbound weight loss works? But are there roadblocks? Looking ahead: The final word: The …